All Stories

  1. Quantitative assessment of the 3D pore space and microglobule clustering network to understand chromatographic transport phenomena in polymeric monolithic columns
  2. Infection history imprints prolonged changes to the epigenome, transcriptome and function of Kupffer cells
  3. Beyond the VSG layer: Exploring the role of intrinsic disorder in the invariant surface glycoproteins of African trypanosomes
  4. Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids
  5. Immunology of African Trypanosomiasis
  6. Trypanosomiasis
  7. Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy
  8. A few good reasons to use nanobodies for cancer treatment
  9. Hallmarks of Cancer Affected by the MIF Cytokine Family
  10. Differential plasticity and fate of brain-resident and recruited macrophages during the onset and resolution of neuroinflammation
  11. The Role of MIF and IL-10 as Molecular Yin-Yang in the Modulation of the Host Immune Microenvironment During Infections: African Trypanosome Infections as a Paradigm
  12. Detrimental Effect ofTrypanosoma brucei bruceiInfection on Memory B Cells and Host Ability to Recall Protective B-cell Responses
  13. Targeting the tsetse-trypanosome interplay using genetically engineered Sodalis glossinidius
  14. Macrophages are metabolically heterogeneous within the tumor microenvironment
  15. The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy
  16. Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation
  17. Immunogenicity Risk Profile of Nanobodies
  18. A Critical Blimp-1-Dependent IL-10 Regulatory Pathway in T Cells Protects From a Lethal Pro-inflammatory Cytokine Storm During Acute Experimental Trypanosoma brucei Infection
  19. Dehydrin ERD14 activates glutathione transferase Phi9 in Arabidopsis thaliana under osmotic stress
  20. Development of a recombinase polymerase amplification lateral flow assay for the detection of active Trypanosoma evansi infections
  21. A New Family of Diverse Skin Peptides from the Microhylid Frog Genus Phrynomantis
  22. Hepatocyte-derived IL-10 plays a crucial role in attenuating pathogenicity during the chronic phase of T. congolense infection
  23. Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
  24. The Trypanosomal Transferrin Receptor of Trypanosoma Brucei—A Review
  25. Neutrophils enhance early Trypanosoma brucei infection onset
  26. Novel half-life extended anti-MIF nanobodies protect against endotoxic shock
  27. The anuran skin peptide bradykinin mediates its own absorption across epithelial barriers of the digestive tract
  28. African Trypanosomiasis-Associated Anemia: The Contribution of the Interplay between Parasites and the Mononuclear Phagocyte System
  29. MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset
  30. Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis
  31. Reprint of: The non-mammalian MIF superfamily
  32. African Trypanosomes Undermine Humoral Responses and Vaccine Development: Link with Inflammatory Responses?
  33. The non-mammalian MIF superfamily
  34. Early Immunological Responses Upon Tsetse Fly–Mediated Trypanosome Inoculation
  35. List of Contributors
  36. MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis
  37. Immune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to Pathogenicity
  38. Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis
  39. An Anti-proteome Nanobody Library Approach Yields a Specific Immunoassay for Trypanosoma congolense Diagnosis Targeting Glycosomal Aldolase
  40. The Possible Role of Staphylococcus epidermidis LPxTG Surface Protein SesC in Biofilm Formation
  41. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
  42. E-cadherin expression in macrophages dampens their inflammatory responsiveness in vitro, but does not modulate M2-regulated pathologies in vivo
  43. NK-, NKT- and CD8-Derived IFNγ Drives Myeloid Cell Activation and Erythrophagocytosis, Resulting in Trypanosomosis-Associated Acute Anemia
  44. Macrophage dynamics are regulated by local macrophage proliferation and monocyte recruitment in injured pancreas
  45. Development of a pHrodo-Based Assay for the Assessment of In Vitro and In Vivo Erythrophagocytosis during Experimental Trypanosomosis
  46. Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm
  47. Murine Liver Myeloid Cell Isolation Protocol
  48. Iron Homeostasis andTrypanosoma bruceiAssociated Immunopathogenicity Development: A Battle/Quest for Iron
  49. Generation of a Nanobody Targeting the Paraflagellar Rod Protein of Trypanosomes
  50. MIF Contributes to Trypanosoma brucei Associated Immunopathogenicity Development
  51. Antibody-mediated control ofTrypanosoma vivaxinfection fails in the absence of tumour necrosis factor
  52. Presence and regulation of insulin-regulated aminopeptidase in mouse macrophages
  53. Antibacterial activities of coagulase-negative staphylococci from bovine teat apex skin and their inhibitory effect on mastitis-related pathogens
  54. Low Structural Variation in the Host-Defense Peptide Repertoire of the Dwarf Clawed Frog Hymenochirus boettgeri (Pipidae)
  55. African Trypanosomiasis as Paradigm for Involvement of the Mononuclear Phagocyte System in Pathogenicity During Parasite Infection
  56. A Trypanosoma brucei Kinesin Heavy Chain Promotes Parasite Growth by Triggering Host Arginase Activity
  57. Origin and Functional Diversification of an Amphibian Defense Peptide Arsenal
  58. Characterization of central macrophages in Anemia of Inflammation (AI): African trypanosomiasis as a model system
  59. Correction: Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
  60. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism
  61. Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
  62. Tsetse Salivary Gland Proteins 1 and 2 Are High Affinity Nucleic Acid Binding Proteins with Residual Nuclease Activity
  63. Vaccination with SesC Decreases Staphylococcus epidermidis Biofilm Formation
  64. Using microdialysis to analyse the passage of monovalent nanobodies through the blood–brain barrier
  65. Expression and extracellular release of a functional anti-trypanosome Nanobody® in Sodalis glossinidius, a bacterial symbiont of the tsetse fly
  66. Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses
  67. IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member inTrypanosoma congolenseinfection-resistant C57BL/6 mice
  68. High Affinity Nanobodies against the Trypanosome brucei VSG Are Potent Trypanolytic Agents that Block Endocytosis
  69. Lack of galectin-3 alleviates trypanosomiasis-associated anemia of inflammation
  70. Tip-DC Development during Parasitic Infection Is Regulated by IL-10 and Requires CCL2/CCR2, IFN-γ and MyD88 Signaling
  71. Current status of vaccination against African trypanosomiasis
  72. Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis
  73. The Central Role of Macrophages in Trypanosomiasis-Associated Anemia:Rationale for Therapeutical Approaches
  74. Identification of a Parasitic Immunomodulatory Protein Triggering the Development of Suppressive M1 Macrophages during African Trypanosomiasis
  75. Differentiation, activation and function of CD11b+Ly6C+ TNF/iNOS-producing dendritic cells during parasitic infection
  76. Understanding the role of monocytic cells in liver inflammation using parasite infection as a model
  77. Inhibition of Staphylococcus epidermidis Biofilm Formation by Rabbit Polyclonal Antibodies against the SesC Protein
  78. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice
  79. Camelid immunoglobulins and nanobody technology
  80. Role of iron homeostasis in trypanosomiasis-associated anemia
  81. Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens
  82. A Glycosylphosphatidylinositol-Based Treatment Alleviates Trypanosomiasis-Associated Immunopathology
  83. African trypanosomosis: From immune escape and immunopathology to immune intervention
  84. Traitement expérimental de la trypanosomiase africaine par le facteur trypanolytique humain combiné à un nanocorps
  85. Tsetse Fly Saliva Accelerates the Onset of Trypanosoma brucei Infection in a Mouse Model Associated with a Reduced Host Inflammatory Response
  86. Evidence for proteins involved in prophenoloxidase cascade Eisenia fetida earthworms
  87. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
  88. The Induction of a Type 1 Immune Response following a Trypanosoma brucei Infection Is MyD88 Dependent
  89. Antigen Binding and Solubility Effects upon the Veneering of a Camel VHH in Framework-2 to Mimic a VH
  90. P75 Tumor Necrosis Factor–Receptor Shedding Occurs as a Protective Host Response during African Trypanosomiasis
  91. Efficient Targeting of Conserved Cryptic Epitopes of Infectious Agents by Single Domain Antibodies
  92. VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology
  93. Control of Experimental Trypanosoma brucei Infections Occurs Independently of Lymphotoxin-α Induction
  94. Bacterial Lipoprotein-Based Vaccines Induce Tumor Necrosis Factor-Dependent Type 1 Protective Immunity against Leishmania major
  95. Distinct Carbohydrate Recognition Domains of an Invertebrate Defense Molecule Recognize Gram-negative and Gram-positive Bacteria
  96. A Conserved Flagellar Pocket Exposed High Mannose Moiety Is Used by African Trypanosomes as a Host Cytokine Binding Molecule
  97. Attenuation ofTrypanosoma bruceiIs Associated with Reduced Immunosuppression and Concomitant Production of Th2 Lymphokines
  98. Comparative Analysis of Antibody Responses against HSP60, Invariant Surface Glycoprotein 70, and Variant Surface Glycoprotein Reveals a Complex Antigen-Specific Pattern of Immunoglobulin Isotype Switching during Infection byTrypanosoma brucei
  99. Detection of clinically relevant antibodies pretransplant and posttransplant with PRA-STAT